PharmaBoardroom Releases New Mauritius Pharmaceuticals Report
Focus Reports today releases its new Mauritius Healthcare and Life Sciences Report 2016.
Mauritius is in the process of rebranding itself as a business-friendly, technologically advanced hub for the pharma industry that will act as a bridge between Asia and Africa. This report offers companies, investors, policymakers, and stakeholders crucial insight into this thriving, vibrant country and market.
It features an exclusive in-depth interview with the President of Mauritius, Ameenah Gurib-Fakim, as well as interviews with senior executives from the island’s major companies and leaders of its most important institutions. The report also contains updated facts and figures on Mauritius’s healthcare and pharma sectors.
This report is an authoritative assessment of one of Mauritius’s leading industries. Mauritius is on its way to becoming:
“A Smart Island” – As part of its “Vision 2030” plan, Mauritius is moving away from its “sun and sand” image and seriously investing in smart cities, bioparks, higher education, and clinical research.
“A Bridge to Africa” – The politically stable and investment-friendly island is located off the east African coast, allowing easy access to the huge, untapped markets on the mainland for both MNCs and SMEs alike. Mauritius is also well connected with India and China in Asia.
“An Investment Paradise” – Income and corporate tax is set at 15 percent, the legal system is robust, the fiscal system has been simplified, and the current government has removed much needless red tape from the healthcare and life sciences industries after identifying it as a key growth driver.
The Mauritius Healthcare and Life Sciences Report 2016 includes features and articles on:
- President Gurib-Fakim’s background as a renowned scientist
- The meaning of “The Ocean Economy”
- The government’s prioritization of HCLS
- Clinical Research
- SMEs in Mauritius
- Vision 2030 explained
- Smart cities
The report also includes interviews with:
- Ameenah Gurib-Fakim, President of the Republic of Mauritius
- Ken Poonoosamy, Mauritius Board of Investments
- Salim Ismail, Groupe SOCOTA
- Dr. Arjoon Suddhoo, Mauritius Research Council
- Arnaud Lagesse, GML
- Samer Kassem, Aspen
- Paul Corson, Mauritius Commercial Bank
- Daniel de Labauve d’Arifat, Pharmacie Nouvelle Limited
- “The time has come to reach beyond the stereotypical image of ‘sun and sea’ and rebrand Mauritius in accordance with our strengths as “the intelligent island.”
Ameenah Gurib-Fakim, President of the Republic of Mauritius
- Life Sciences will contribute to transform Mauritius into a high-income economy in the coming years”
Ken Poonoosamy, Mauritius Board of Investments
- The aspiration for Mauritius is to be renowned as the most innovative country in the world.”
Dr. Arjoon Suddhoo, Mauritius Research Council
- [Mauritius] can offer leading services, quality solutions and speedy drug discovery processes at a fraction of European costs.”
Arnaud Lagesse, GML
- Mauritius offers unique incentives that encourage investment in a politically liberal context.”
Samer Kassem, Aspen